Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 1987, Technomark Life Sciences is a global investment group specializing in the life sciences sector. The firm focuses on strategic planning, venture capital, and product development, primarily in the United States and Europe. Technomark operates a co-development investment business model, providing turn-key solutions for clinical development programs.
Technomark invests in the therapeutics sector, including biologics, new chemical entities (NCE), orphan drugs, medical technology, and devices/diagnostics. The firm targets companies in Phase I-IV clinical trials, engaging in investments from seed to Series C stages.
What stages does Technomark Life Sciences invest in?
Technomark invests in companies at various stages, including seed, Series A, Series B, and Series C.
What sectors does Technomark focus on?
The firm primarily focuses on the life sciences sector, particularly therapeutics and medical technology.
Where does Technomark primarily operate?
Technomark operates globally, with a strong emphasis on the United States and Europe.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.